Published in J Am Coll Cardiol on June 01, 1997
Mechanism of augmented exercise hyperpnea in chronic heart failure and dead space loading. Respir Physiol Neurobiol (2012) 2.07
The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev (2007) 1.65
Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy. Heart (2015) 1.40
Causes of breathing inefficiency during exercise in heart failure. J Card Fail (2010) 1.13
Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure. Circ Heart Fail (2009) 1.13
Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone. Circ Heart Fail (2008) 1.09
MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study. BMC Pulm Med (2010) 1.06
Cardiopulmonary exercise testing and its application. Postgrad Med J (2007) 1.06
Cardiopulmonary exercise testing and its application. Heart (2007) 1.02
Serial cardiopulmonary exercise testing in patients with previous Fontan surgery. Pediatr Cardiol (2010) 1.01
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail (2013) 1.00
Left ventricular assist device: a functional comparison with heart transplantation. Neth Heart J (2008) 0.95
Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart (2000) 0.94
Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax (2002) 0.93
Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure. J Physiol (2000) 0.93
Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement. Heart (2000) 0.91
Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure. Eur J Heart Fail (2010) 0.91
Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension. BMC Pulm Med (2012) 0.90
The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure. Am Heart J (2009) 0.87
Heart failure: What causes the symptoms of heart failure? Heart (2001) 0.86
New York Heart Association functional class predicts exercise parameters in the current era. Am Heart J (2009) 0.86
Serum cholinesterase is an important prognostic factor in chronic heart failure. Heart Vessels (2014) 0.84
Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart (2003) 0.83
The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. Biomed Res Int (2014) 0.82
Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev (2007) 0.81
Baseline differences in the HF-ACTION trial by sex. Am Heart J (2009) 0.81
Physiology of oxygen uptake kinetics: Insights from incremental cardiopulmonary exercise testing in the Study of Health in Pomerania. IJC Metab Endocr (2015) 0.80
The role of exercise testing in the evaluation and management of heart failure. Postgrad Med J (1999) 0.80
Exercise testing in the assessment of chronic congestive heart failure. Heart (2002) 0.79
Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction. Respir Res (2015) 0.79
Obstructive sleep apnea is associated with impaired exercise capacity: a cross-sectional study. J Clin Sleep Med (2014) 0.79
Guidelines for heart transplantation. Neth Heart J (2008) 0.79
A Systematic Review of Reference Values in Pediatric Cardiopulmonary Exercise Testing. Pediatr Cardiol (2015) 0.79
Validation of the Innocor device for noninvasive measurement of oxygen consumption in children and adults. Pediatr Cardiol (2012) 0.78
The results of cardiopulmonary exercise test in healthy Korean children and adolescents: single center study. Korean J Pediatr (2013) 0.78
Clinical usefulness of response profiles to rapidly incremental cardiopulmonary exercise testing. Pulm Med (2013) 0.78
Ventilatory gas exchange and early response to cardiac resynchronization therapy. J Heart Lung Transplant (2015) 0.78
Red cell distribution width as an independent predictor of exercise intolerance and ventilatory inefficiency in patients with chronic heart failure. Yonsei Med J (2014) 0.77
The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction. Clin Res Cardiol (2008) 0.77
Metabolic parameters derived from cardiopulmonary stress testing for prediction of prognosis in patients with heart failure: the ochsner experience. Ochsner J (2009) 0.77
Cardiopulmonary exercise testing is predictive of return to work in cardiac patients after multicomponent rehabilitation. Clin Res Cardiol (2015) 0.77
Noninvasive ventilation and exercise tolerance in heart failure: A systematic review and meta-analysis. Braz J Phys Ther (2014) 0.76
Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs. Am J Phys Med Rehabil (2012) 0.76
Oxygen uptake in heart failure: how much, how fast? Neth Heart J (2009) 0.76
Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease. Open Heart (2016) 0.75
Abnormalities of the ventilatory equivalent for carbon dioxide in patients with chronic heart failure. Pulm Med (2012) 0.75
Short-term modulation of the ventilatory response to exercise is preserved in obstructive sleep apnea. Respir Physiol Neurobiol (2016) 0.75
Cardiopulmonary Exercise Test: Background, Applicability and Interpretation. Arq Bras Cardiol (2016) 0.75
Effect of exercise training on ventilatory efficiency in patients with heart disease: a review. Braz J Med Biol Res (2016) 0.75
Influence of body mass on risk prediction during cardiopulmonary exercise testing in patients with chronic heart failure. Exp Clin Cardiol (2012) 0.75
Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation Therapy. J Pediatr Hematol Oncol (2015) 0.75
Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction. Heart (2003) 0.75
[Functional capacity as a criterion for patient selection--too poor or too good for CRT?]. Herzschrittmacherther Elektrophysiol (2006) 0.75
Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol (1997) 16.86
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J (2000) 4.99
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation (1997) 4.09
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Thiamine in our bread and wine? Med J Aust (1990) 3.09
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
The endotoxin-lipoprotein hypothesis. Lancet (2000) 3.03
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2000) 2.85
Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J (1998) 2.73
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet (2003) 2.64
Heart failure in a district general hospital. J R Coll Physicians Lond (1992) 2.61
Hospitalization of patients with heart failure: a population-based study. Eur Heart J (2002) 2.54
Practice nurses' workload and consultation patterns. Br J Gen Pract (1995) 2.50
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Knowledge and communication difficulties for patients with chronic heart failure: qualitative study. BMJ (2000) 2.47
Screening for hypertrophic cardiomyopathy. BMJ (1993) 2.31
Pathogenesis of edema in constrictive pericarditis. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones before and after pericardiectomy. Circulation (1991) 2.28
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1997) 2.27
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Respiratory gas exchange in the assessment of patients with impaired ventricular function. Br Heart J (1985) 2.17
Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) (1986) 2.09
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther (1999) 2.06
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J (2000) 2.06
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation (1993) 2.05
Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia? Br J Obstet Gynaecol (1993) 2.04
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J (1990) 2.00
Severity of heart failure and dosage of angiotensin converting enzyme inhibitors. BMJ (1995) 1.99
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Hypoxia and calcium. J Mol Cell Cardiol (1979) 1.94
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation (1996) 1.88
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J (2004) 1.84
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol (2001) 1.79
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med (1992) 1.76
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation (2000) 1.72
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol (1999) 1.71